No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Solta Medical Launches the Clear + Brilliant Touch Laser

Editor: What To Know

  • In addition to offering easy access to both the Original and Perméa® handpieces in the compact system, the Clear + Brilliant® Touch laser also includes a user-friendly touchscreen, a simple training mode to simulate treatment without emitting laser energy and a smart charting assistant that automatically tracks treatment progress with the ability to export patient treatment charts.
  • “As pioneers in the aesthetic market, Solta Medical has continued to evolve the Clear + Brilliant® technology to improve upon the efficiency and convenience that physicians and their patients have come to expect from Solta Medical.
  • Solta Medica*l notes the Clear + Brilliant Touch Laser delivers a customized and more comprehensive treatment protocol by providing patients of all ages and skin types the benefits of two wavelengths.

Solta Medica*l notes the Clear + Brilliant Touch Laser delivers a customized and more comprehensive treatment protocol by providing patients of all ages and skin types the benefits of two wavelengths.

By seamlessly switching between two wavelengths with the Original and Perméa® handpieces, physicians can now more easily deliver a more complete treatment during a single appointment.

“The new innovative features of the Clear + Brilliant® Touch laser are designed to make the system easier and more convenient to use. Aesthetic providers can now more efficiently offer patients a complete treatment using two wavelengths by seamlessly switching between the Original and Perméa® handpieces during one appointment. We believe physicians and their patients will experience a real advantage with the new Clear + Brilliant® Touch laser,” said Tom Hart, global vice president, Solta Medical. “As pioneers in the aesthetic market, Solta Medical has continued to evolve the Clear + Brilliant® technology to improve upon the efficiency and convenience that physicians and their patients have come to expect from Solta Medical.”

In addition to offering easy access to both the Original and Perméa® handpieces in the compact system, the Clear + Brilliant® Touch laser also includes a user-friendly touchscreen, a simple training mode to simulate treatment without emitting laser energy and a smart charting assistant that automatically tracks treatment progress with the ability to export patient treatment charts.

“The Clear + Brilliant® laser is an easy-to-use and transportable system that has been a mainstay in my practice for years. The new system, the Clear + Brilliant® Touch laser offers even more versatility,  for my patients. Having the option to use both wavelengths seamlessly during one appointment will be a welcome addition to my practice and to my patients,” said Jeffrey S. Dover, M.D., FRCPC, a board-certified dermatologist in Boston, MA.

*Solta Medical, part of the Ortho Dermatologics business of Bausch Health Companies Inc., is a global leader in the medical aesthetics market that helps drive revenue growth to aesthetic practices by providing innovative and effective skin rejuvenation and body contouring solutions. Solta Medical’s vision is to develop and support trusted aesthetic brands that provide value and lasting growth to physicians and patients. These include the Thermage® RF systems, Fraxel® laser, Clear + Brilliant® laser and VASER® ultrasonic systems. More than six million procedures have been performed with Solta Medical’s portfolio of products around the world.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy